Moderna Stock Has Run Too Far, Too Fast. Why Citi Just Downgraded It to Sell.

Citi downgrades Moderna to Sell from Hold, saying the data around its cancer vaccine, instimeran autogene, isn't enough to justify the valuation.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。